The Global Pain Management Market Size accounted for USD 48,518 Million in 2021 and is estimated to garner a market size of USD 83,348 Million by 2030 rising at a CAGR of 6.5% from 2022 to 2030. Increasing cases on chronic pain is the prominent factor that is boosting the global pain management market growth. In addition to that, rising demand for chronic pain management in home care settings is pushing the market growth forward for the coming future. Furthermore, growing drugs and devices to reduce pain is the recent pain management market trend that is intensifying the industry growth.
Pain Management Market Report Key Highlights
- Global pain management market revenue is poised to garner USD 83,348 Million by 2030 with a CAGR of 6.5% from 2022 to 2030
- North America dominated the maximum market with over 40% shares in 2021
- According to CDC, chronic pain affected more than 100 million Americans in 2018
- Asia-Pacific pain management market is poised to grow with a significant CAGR from 2022 to 2030
- Based on application segment, neuropathic pain gathered more than 30% of the total market share in 2021
- Surging number of sport injuries propels the pain management market value
Gradual increase in number of patients suffering from chronic cancer and diabetes, coupled with high government spending on hospital infrastructure in order to provide enhanced care are major factors expected to drive the growth of global market. According to U.S. Department of Health & Human Services in 2016, an estimated 20.4% of U.S. adults (50.0 million) had chronic pain and 8.0% of U.S. adults (19.6 million) had high-impact chronic pain.
Global Pain Management Market Dynamics
Market Drivers
- Growing incidences of chronic pain
- Rising prevalence of sport injuries
- Increasing number of surgical procedures
- Huge base of elderly population
Market Restraints
- High purchase and procedural cost of pain management devices
- Availability of other therapies
Market Opportunities
- Rapid advancements in drug development
- Expanding base of pain management clinics and centers throughout the world
Pain Managements Market Report Coverage
Market |
Pain Management Market |
Pain Management Market Size 2021 |
USD 48,518 Million |
Pain Management Market Forecast 2030 |
USD 83,348 Million |
Pain Management Market CAGR During 2022 - 2030 |
6.5% |
Pain Management Market Analysis Period |
2018 - 2030 |
Pain Management Market Base Year |
2021 |
Pain Management Market Forecast Data |
2022 - 2030 |
Segments Covered |
By Mode Of Pain Management, By Application, And By Geography
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled |
Abbott Laboratories, AstraZeneca PLC, Baxter International Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Fresenius SE & Co. KGaA, GlaxoSmithKline PLC, Johnson & Johnson, Medtronic PLC, Novartis International AG, Pfizer Inc, and others. |
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Pain Management Market Insights
Favorable business policies and emergence of small and mid-size enterprises with advanced solutions are factors expected to support the growth of target market. In addition, players focus on tracking the untapped market in developing countries is expected to support the growth of target market.
However, factors such as high cost of devices and stringent government regulations related to product approval are expected to hamper the growth of global pain management market. In addition, lack of advanced infrastructure in developing countries for adoption of advanced devices is expected to challenge the growth of target market.
Rapid technological advancements by major players, integration of AI in devices coupled with introduction of innovative solutions are factors responsible to create new opportunities for players operating in the target market over the forecast period. In addition, increasing partnership and agreements between regional and international players is expected to support the revenue growth of target market
Pain Management Market Segmentation
The worldwide pain management market is split based on mode of pain management, application, and geography.
Pain Management Market By Mode Of Pain Management
- Drugs
- Opioids
- Non-Narcotic Analgesics
- NSAIDS
- Anesthetics
- Anticonvulsants
- Anti-Depressants
- Other Non-Narcotic Analgesics
- Devices
- Neurostimulation Devices
- Transcutaneous Electrical Nerve Stimulation (TENS) Devices
- Brain and Spinal Cord Stimulation (SCS) Devices
- Analgesic Infusion Pumps
- Intrathecal Infusion Pumps
- External Infusion Pumps
According to our pain management industry analysis, the drugs accounted for a considerable market share in 2021. Among al the dugs, opioids category was the largest contributor to the market in 2021 because of opioids' great efficiency in relieving pain in major chronic illnesses. During the projection period, the anaesthetics segment is expected to increase at the fastest rate. Among all the devices, neurostimulation devices dominated the market with significant pain management market share.
Pain Management Market By Application
- Neuropathic Pain
- Cancer Pain
- Facial Pain and Migraine
- Musculoskeletal Pain
- Other Applications
Acccodting to pain management market forecast, the neuropathic pain application occupied a noteworthy market share from 2022 to 2030. The presence of a big patient population is a crucial factor driving up demand for pharmaceuticals in the market. Neuropathic pain affects between 3% and 17% of persons. Furthermore, cancer pain and chronic back pain are predicted to expand at the fastest rates during the forecast period, owing to an increase in the number of operations worldwide and an increase in the incidence of chronic diseases that cause back pain.
Pain Management Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
The Middle East & Africa (MEA)
- Gulf Cooperation Council (GCC)
- South Africa
- Rest of the Middle East & Africa
According to CDC over 65% of the US elderly population suffers from chronic pain
The North America pain management market is expected to account for significant revenue share owing to availability of enhanced pain care management, increasing number of patients suffering from chronic diseases, availability of favorable insurance policies, and growing base of aging population. With an increase in the older population, the market is predicted to grow at a faster rate, as the ageing population is more susceptible to chronic illness. Presence of large number of players operating in the country and approach towards introduction of innovative solutions are factors expected to boost the growth of target market. During the projection period, the Asia-Pacific pain management market is expected to develop at the fastest rate. This expansion can be attributed to R&D efforts in the development of technologically advanced healthcare treatment solutions.
Pain Management Market Players
Some of the top pain management companies offered in the professional report include Abbott Laboratories, AstraZeneca PLC, Baxter International Inc., Becton, Dickinson and Company, Boston Scientific Corporation, Fresenius SE & Co. KGaA, GlaxoSmithKline PLC, Johnson & Johnson, Medtronic PLC, Novartis International AG, and Pfizer Inc.
Increasing investment by major players for R&D activities, and approach towards introduction of smart devices are factors responsible for the growth of target market. In addition, strategic merger and acquisition activities by major players in order to enhance the business presence are factors expected to augment the growth of target market.
In 2019, NeuroPace, Inc. launched Senza® Omnia™ Spinal Cord Stimulation System in the US for the treatment of chronic pain. This is expected to help the company to enhance the product portfolio and enhance the profit ratio.
In 2018, Abbott a multinational medical devices and health care company signed an agreement with National Institutes of Health (NIH), US in order to provide neuromodulation technologies, including directional DBS, SCS, and DRG therapy, for NIH research and further explore the applications.
In 2019, Boston Scientific Corp. engages launched Spectra WaveWriter™ Spinal Cord Stimulator System for treatment of chronic pain and simultaneously combine paresthesia-based and sub-perception therapy in Europe. This is expected to help the company to strengthen its position in Europe.
In 2018, NeuroPace a global operating company that designs, develops, manufactures and market implantable devices for the treatment of neurological disorders launched RNS system for treatment of refractory epilepsy. This is expected to help the company to enhance the customer base.
CHAPTER 1. Industry Overview of Pain Management Market
1.1. Definition and Scope
1.1.1. Definition of Pain Management
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Pain Management Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Pain Management Market By Mode Of Pain Management
1.2.3. Pain Management Market By Application
1.2.4. Pain Management Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Pain Management Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Pain Management Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Pain Management Market By Mode Of Pain Management
4.1. Introduction
4.2. Pain Management Revenue By Mode Of Pain Management
4.2.1. Pain Management Revenue (USD Million) and Forecast, By Mode Of Pain Management, 2018-2030
4.2.2. Drugs
4.2.2.1. Drugs Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.2. Opioids
4.2.2.2.1. Opioids Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.3. Non-Narcotic Analgesics
4.2.2.3.1. Non-Narcotic Analgesics Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.3.2. NSAIDS
4.2.2.3.2.1. NSAIDS Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.3.3. Anesthetics
4.2.2.3.3.1. Anesthetics Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.3.4. Anticonvulsants
4.2.2.3.4.1. Anticonvulsants Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.3.5. Anti-Depressants
4.2.2.3.5.1. Anti-Depressants Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.2.3.6. Other Non-Narcotic Analgesics
4.2.2.3.6.1. Other Non-Narcotic Analgesics Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3. Devices
4.2.3.1. Devices Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3.2. Neurostimulation Devices
4.2.3.2.1. Neurostimulation Devices Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3.2.2. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
4.2.3.2.2.1. Transcutaneous Electrical Nerve Stimulation (TENS) Devices Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3.2.3. Brain and Spinal Cord Stimulation (SCS) Devices
4.2.3.2.3.1. Brain and Spinal Cord Stimulation (SCS) Devices Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3.3. Analgesics Infusion Pumps
4.2.3.3.1. Analgesics Infusion Pumps Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3.3.2. Intrathecal Infusion Pumps
4.2.3.3.2.1. Intrathecal Infusion Pumps Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3.3.3. External Infusion Pumps
4.2.3.3.3.1. External Infusion Pumps Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 5. Pain Management Market By Application
5.1. Introduction
5.2. Pain Management Revenue By Application
5.2.1. Pain Management Revenue (USD Million) and Forecast, By Application, 2018-2030
5.2.2. Neuropathic Pain
5.2.2.1. Neuropathic Pain Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3. Cancer Pain
5.2.3.1. Cancer Pain Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.4. Facial Pain and Migraine
5.2.4.1. Facial Pain and Migraine Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.5. Musculoskeletal Pain
5.2.5.1. Musculoskeletal Pain Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.6. Other Applications
5.2.6.1. Other Applications Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 6. North America Pain Management Market By Country
6.1. North America Pain Management Market Overview
6.2. U.S.
6.2.1. U.S. Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
6.2.2. U.S. Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
6.3. Canada
6.3.1. Canada Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
6.3.2. Canada Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
6.4. North America PEST Analysis
CHAPTER 7. Europe Pain Management Market By Country
7.1. Europe Pain Management Market Overview
7.2. U.K.
7.2.1. U.K. Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
7.2.2. U.K. Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
7.3. Germany
7.3.1. Germany Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
7.3.2. Germany Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
7.4. France
7.4.1. France Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
7.4.2. France Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
7.5. Spain
7.5.1. Spain Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
7.5.2. Spain Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
7.6. Rest of Europe
7.6.1. Rest of Europe Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
7.6.2. Rest of Europe Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
7.7. Europe PEST Analysis
CHAPTER 8. Asia Pacific Pain Management Market By Country
8.1. Asia Pacific Pain Management Market Overview
8.2. China
8.2.1. China Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
8.2.2. China Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
8.3. Japan
8.3.1. Japan Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
8.3.2. Japan Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
8.4. India
8.4.1. India Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
8.4.2. India Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
8.5. Australia
8.5.1. Australia Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
8.5.2. Australia Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
8.6. South Korea
8.6.1. South Korea Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
8.6.2. South Korea Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
8.7. Rest of Asia-Pacific
8.7.1. Rest of Asia-Pacific Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
8.7.2. Rest of Asia-Pacific Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
8.8. Asia Pacific PEST Analysis
CHAPTER 9. Latin America Pain Management Market By Country
9.1. Latin America Pain Management Market Overview
9.2. Brazil
9.2.1. Brazil Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
9.2.2. Brazil Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
9.3. Mexico
9.3.1. Mexico Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
9.3.2. Mexico Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
9.4. Rest of Latin America
9.4.1. Rest of Latin America Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
9.4.2. Rest of Latin America Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
9.5. Latin America PEST Analysis
CHAPTER 10. Middle East & Africa Pain Management Market By Country
10.1. Middle East & Africa Pain Management Market Overview
10.2. GCC
10.2.1. GCC Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
10.2.2. GCC Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
10.3. South Africa
10.3.1. South Africa Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
10.3.2. South Africa Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
10.4. Rest of Middle East & Africa
10.4.1. Rest of Middle East & Africa Pain Management Revenue (USD Million) and Forecast By Mode Of Pain Management, 2018-2030
10.4.2. Rest of Middle East & Africa Pain Management Revenue (USD Million) and Forecast By Application, 2018-2030
10.5. Middle East & Africa PEST Analysis
CHAPTER 11. Player Analysis Of Pain Management Market
11.1. Pain Management Market Company Share Analysis
11.2. Competition Matrix
11.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
11.2.2. New Product Launches and Product Enhancements
11.2.3. Mergers And Acquisition In Global Pain Management Market
11.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 12. Company Profile
12.1. Abbott Laboratories
12.1.1. Company Snapshot
12.1.2. Business Overview
12.1.3. Financial Overview
12.1.3.1. Revenue (USD Million), 2021
12.1.3.2. Abbott Laboratories 2021 Pain Management Business Regional Distribution
12.1.4. Product /Service and Specification
12.1.5. Recent Developments & Business Strategy
12.2. AstraZeneca PLC
12.3. Baxter International Inc.
12.4. Becton, Dickinson and Company
12.5. Boston Scientific Corporation
12.6. Fresenius SE & Co. KGaA
12.7. GlaxoSmithKline PLC
12.8. Johnson & Johnson
12.9. Medtronic PLC
12.10. Novartis International AG
12.11. Pfizer Inc